Good call overall. I still think NP gives the E
Post# of 153434
(Total Views: 530)
Posted On: 09/02/2020 5:17:25 PM
Good call overall.
I still think NP gives the EFF-DA too much credit. If the EFF-DA was so keen on fast-tracking leronlimab by granting ph2 and ph3 trials, then WTF are they now sputtering to give EUA after a gold-standard, double-blind, accept every applicant without exception, no-one-wants-to-touch m2m group, with statistical significance proving efficacy? Is it that they think its too good to be true?
I still think NP gives the EFF-DA too much credit. If the EFF-DA was so keen on fast-tracking leronlimab by granting ph2 and ph3 trials, then WTF are they now sputtering to give EUA after a gold-standard, double-blind, accept every applicant without exception, no-one-wants-to-touch m2m group, with statistical significance proving efficacy? Is it that they think its too good to be true?
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼